Roberto Filippi

机构：Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Turin · ORCID：0000-0001-9698-7687

发表论文 82 篇 · 总被引 985 次 · h-index 16

代表论文

• Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes (2020 · The Oncologist · 被引 113)
• The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer (2019 · Liver International · 被引 59)
• Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors (2024 · JAMA Network Open · 被引 48)
• Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations (2019 · European Journal of Cancer · 被引 44)
• Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors (2022 · npj Precision Oncology · 被引 29)
• Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from 68Ga-DOTATOC PET/CT in Well-Differentiated Neuroendocrine Tumors (2021 · Journal of Nuclear Medicine · 被引 28)